Immuneering
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $360 | $0 | $0 |
Gross Profit | -190 | 180 | -180 | -612 |
EBITDA | -25,598 | -17,178 | -15,246 | -14,085 |
EBIT | -25,788 | -17,270 | -15,335 | -14,168 |
Net Income | -24,192 | -17,270 | -13,460 | -11,580 |
Net Change In Cash | 0 | 360 | 0 | 0 |
Free Cash Flow | -51,807,503 | -16,528 | -18,513 | -9,964 |
Cash | 58,226 | 41,324 | 47,321 | 128,645 |
Basic Shares | 64,714 | 64,697 | 64,658 | 64,590 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $ | $316 |
Gross Profit | -698 | -713 | -764 | 158 |
EBITDA | -55,671 | -63,686 | -58,061 | -51,468 |
EBIT | -56,024 | -64,071 | -58,413 | -51,745 |
Net Income | -56,024 | -61,036 | -53,471 | -50,513 |
Net Change In Cash | 0 | 0 | 316 | |
Cost of Revenue | -2,251 | |||
Free Cash Flow | -45,486 | -55,084 | -49,311 | -44,843 |
Cash | 128,645 | 36,144 | 59,405 | 72,636 |
Basic Shares | 44,011 | 29,981 | 28,416 | 26,386 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.37 |
2026-06-30 | -$0.27 |
2026-03-31 | -$0.21 |
2025-12-31 | -$0.18 |